MASC construct validity

Click any row to open that validity domain in full
MASC indexTotal score (primary)Healthy controlsAutism (ASD)Schizophrenia (SSD)Depression (MDD)Overallall populations
Convergent validityDoes the MASC agree with other mentalizing tests?
Validity:SmallCertainty:Very LowStudies:23
Validity:UnclearCertainty:Very LowStudies:5
Validity:UnclearCertainty:Very LowStudies:3
Validity:UnclearCertainty:Very LowStudies:2
Validity:SmallCertainty:Very LowStudies:24
42studies3,510participants13countries142comparison measures
Germany: 6 studies · 303 participantsFrance: 5 studies · 313 participantsNorway: 5 studies · 491 participantsSpain: 5 studies · 316 participantsSwitzerland: 4 studies · 259 participantsUK: 4 studies · 606 participantsUSA: 4 studies · 437 participantsItaly: 2 studies · 232 participantsSweden: 2 studies · 119 participantsTaiwan: 2 studies · 343 participantsBelgique: 1 studies · 32 participantsMalaysia: 1 studies · 44 participantsMexico: 1 studies · 15 participants
CountryStudies
Germany6
France5
Norway5
Spain5
Switzerland4
UK4
USA4
Italy2
Sweden2
Taiwan2
Belgique1
Malaysia1
Mexico1